2004
DOI: 10.1002/pmic.200300756
|View full text |Cite
|
Sign up to set email alerts
|

Increases in leukocyte cluster of differentiation antigen expression during cardiopulmonary bypass in patients undergoing heart transplantation

Abstract: Cardiopulmonary bypass (CPB) is essential in heart transplantation surgery. It is also used in coronary artery grafting surgery where it has been associated with a postoperative inflammatory response. This manifests as an increase in pro-inflammatory proteins like interleukin-8 and tumour necrosis factor alpha accompanied by increases in neutrophil populations and increased expression of cluster of differentiation (CD) antigens. The latter have been investigated using flow cytometry, which is limited to the me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…For implantable medical device applications, immobilizing proteins by utilizing physical interactions renders the proteins vulnerable to detachment and undesirable conformation changes which affect their bioactivity can lead to adverse responses such as inflammation, clotting, activation of cellular immune response, excessive fibrosis, or rejection. During heart transplantation using cardiopulmonary bypass heart-lung machines, patients exhibit an inflammatory response which is characterized by increased expression of at least ten leukocyte cluster-of-differentiation (CD) antigens [7]. Coronary artery disease is primarily caused by inflammation of coronary vessel walls [8] and a study on coronary stents provided strong evidence that increased inflammation can arise from the use of bare stents [9].…”
Section: Introductionmentioning
confidence: 99%
“…For implantable medical device applications, immobilizing proteins by utilizing physical interactions renders the proteins vulnerable to detachment and undesirable conformation changes which affect their bioactivity can lead to adverse responses such as inflammation, clotting, activation of cellular immune response, excessive fibrosis, or rejection. During heart transplantation using cardiopulmonary bypass heart-lung machines, patients exhibit an inflammatory response which is characterized by increased expression of at least ten leukocyte cluster-of-differentiation (CD) antigens [7]. Coronary artery disease is primarily caused by inflammation of coronary vessel walls [8] and a study on coronary stents provided strong evidence that increased inflammation can arise from the use of bare stents [9].…”
Section: Introductionmentioning
confidence: 99%
“…[12][13][14][15]. However, it soon became clear that these cell microarrays could also be used to detect more subtle changes in leukocyte populations, for example cell activation or inflammatory responses in patients with heart disease [16][17][18] and other inflammatory diseases [19], including SLE, as we describe in this review. We assume that inflammation, whether active or historical, produces a response in CD or other surface proteins on the surface of peripheral blood leukocytes, and that this response can be detected when large numbers of signals are measured simultaneously.…”
Section: Antibody Leukocyte Capture Microarraymentioning
confidence: 99%
“…Another technology that has been used to investigate cell-based inflammatory responses in heart transplantation is the leukocyte antibody array. Increased expression of specific leukocyte cluster of differentiation antigens has been reported during CPB in patients undergoing heart transplantation (102). Furthermore, using a proteomic approach, two myocardial proteins (␣B-crystallin and tropomyosin) have been identified as significantly increased in sera of patients showing histological signs of rejection (103).…”
Section: Genomic Profiling and Risk Of Cardiac Allograft Rejectionmentioning
confidence: 99%